Showing results (111-120 of 687) with videos related to
Sort By:
Pageof 69
Clinical Pharmacology and Therapeutics|May 1, 1978
Metabolism of cocaine in manT Inaba, D J Stewart, W KalowLife Sciences|January 2, 1984
Competitive inhibition of sparteine oxidation in human liver by beta-adrenoceptor antagonists and other cardiovascular drugsS V Otton, T Inaba, W KalowBritish Journal of Clinical Pharmacology|June 1, 1991
Oxidation of reduced haloperidol to haloperidol: involvement of human P450IID6 (sparteine/debrisoquine monooxygenase)R F Tyndale, W Kalow, T InabaBritish Journal of Clinical Pharmacology|May 1, 1986
A simple borohydride/GC method for measuring sparteine metabolites in manT Inaba, A Vinks, S V OttonDrug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1975
N-hydroxyamobarbital: the second major metabolite of amobarbital in manB K Tang, T Inaba, W KalowEuropean Journal of Clinical Pharmacology|October 10, 1975
Comparative drug elimination in man-diphenylhydantoin and amobarbitalJ F Brien, T Inaba, W KalowDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1977
N-Hydroxylation of pentobarbital in manB K Tang, T Inaba, W KalowClinical Pharmacology and Therapeutics|May 1, 1976
Disposition kinetics of two oral forms of quinidineW A Mahon, M Mayersohn, T InabaDrug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1989
Evidence in humans for variant allozymes of the nondeficient sparteine/debrisoquine monooxygenase (P45OIID 1) in vitroR F Tyndale, T Inaba, W KalowLife Sciences|February 14, 1983
Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugsS V Otton, T Inaba, W KalowPageof 69